According to Stratistics MRC, the Global Blood Stream Infection Testing Market is accounted for $4,407.00 million in 2020 and is expected to reach $9,725.14 million by 2028 growing at a CAGR of 10.4% during the forecast period. Surging cases of sepsis and increasing occurrence of infectious ailments, and advancement in healthcare technology are driving the market growth. However, high costs involved in diagnosis and absence of medical compensation are hampering the growth of the market.
Request for a Free Sample Copy of Report at www.strategymrc.com/report/blood-stream-infection-testing-market/request-sample
Based on the product, the instruments segment is going to have lucrative growth during the forecast period as automated instruments are more efficient and provide reliable results in a short time. Moreover, with the help of these instruments the results are more reproducible and operational errors are reduced thereby fueling the demand for segment. By geography, North America is going to have high growth during the forecast period due to factors such as high infection rate, increase in awareness, high diagnosis rate, favorable medical reimbursement scenario, and developed medical facilities in this region.
Some of the key players profiled in the Blood Stream Infection Testing Market include Abbott Laboratories, Accelerate Diagnostics Inc, Beckman Coulter Inc, Becton, Dickinson And Company, Biomérieux Inc., Cepheid Inc, Danaher Corp, F. Hoffmann-La Roche AG, Siemens Healthcare and Thermo Fisher Scientific Inc.
Products Covered:
• Instruments
• Consumables (Reagents)
• Software & Services
Test Types Covered:
• Conventional Blood Culture Tests
• Blood Gases
• Complete Blood Count (CBC)
• Culture of Skin Sore
• Cerebrospinal Fluid (CSF) Culture
• Platelet Count
• Urine Culture
• Chest X-Ray
• Polymerase Chain Reaction (PCR) Method
• Nucleic Acid Testing
• Mass Spectroscopy
• Point-of-Care Testing
• Clotting Studies
Technologies Covered:
• Molecular
• Culture-Based
• Proteomic
Techniques Covered:
• Non-Conventional Testing
• Conventional Testing
• Automated
Applications Covered:
• Fungemia
• Mycobacteria
• Bacteremia
End Users Covered:
• Hospital Laboratories
• Academic Research Laboratories
• Reference Laboratories
• Independent Research & Diagnostic Centers
• Other End Users
Regions Covered:
• North America
o US
o Canada
o Mexico
• Europe
o Germany
o UK
o Italy
o France
o Spain
o Rest of Europe
• Asia Pacific
o Japan
o China
o India
o Australia
o New Zealand
o South Korea
o Rest of Asia Pacific
• South America
o Argentina
o Brazil
o Chile
o Rest of South America
• Middle East & Africa
o Saudi Arabia
o UAE
o Qatar
o South Africa
o Rest of Middle East & Africa
If Any Query? Ask Our Industry Expert at www.strategymrc.com/report/blood-stream-infection-testing-market/request-customization
Explore the list of attractive markets during this time of Pandemic @ www.strategymrc.com/covid-19-impact-reports
About Us:
StrategyMRC research reports and publications are routed to help clients to design their business models and enhance their business growth in the competitive market scenario. We have a strong team with hand-picked consultants including project managers, implementers, industry experts, researchers, research evaluators and analysts with years of experience in delivering the complex projects. We track 30+ industries and cover 800 market segments.
Contact Us:
Stratistics Market Research Consulting
Phone: +1-301-202-5929
Email: info@strategymrc.com
Website: www.strategymrc.com/
Twitter:twitter.com/StratisticsMRC
LinkedIn: www.linkedin.com/company/stratistics-market-research-consulting-pvt-ltd?trk=mini-profile